Intriguingly, numerous studies have implicated FOXO1 in the inhibition of MyoD-mediated myogenic differentiation45–48, and recent work suggests that suppression of MyoD may underlie BTHS-associated skeletal muscle myopathy49. This evidence concerns the gene FOXO1 and Barth syndrome.